DuoX significantly alleviated DEX-induced muscle atrophy and functional decline in C2C12 myotubes and a rodent sarcopenia model, and it was confirmed to inhibit the activation of the UPS, a protein degradation pathway, by downregulating atrogin-1 expression. This evidence concerns the gene FBXO32 and sarcopenia.